Does AXITINIB Cause Immune-mediated hepatitis? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Immune-mediated hepatitis have been filed in association with AXITINIB (INLYTA). This represents 0.1% of all adverse event reports for AXITINIB.
15
Reports of Immune-mediated hepatitis with AXITINIB
0.1%
of all AXITINIB reports
1
Deaths
7
Hospitalizations
How Dangerous Is Immune-mediated hepatitis From AXITINIB?
Of the 15 reports, 1 (6.7%) resulted in death, 7 (46.7%) required hospitalization, and 2 (13.3%) were considered life-threatening.
Is Immune-mediated hepatitis Listed in the Official Label?
Yes, Immune-mediated hepatitis is listed as a known adverse reaction in the official FDA drug label for AXITINIB.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Neoplasm progression (1,315)
Hypertension (1,146)
Off label use (1,075)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
What Other Drugs Cause Immune-mediated hepatitis?
NIVOLUMAB (640)
PEMBROLIZUMAB (549)
IPILIMUMAB (443)
CARBOPLATIN (213)
PACLITAXEL (167)
ATEZOLIZUMAB (142)
BEVACIZUMAB (108)
DURVALUMAB (90)
LENVATINIB (86)
PEMETREXED (86)
Which AXITINIB Alternatives Have Lower Immune-mediated hepatitis Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE